Akso Health Launches Exploratory Global Patient Support Program, Partners with Nanning Duoling Research Institute
ByAinvest
Tuesday, Feb 3, 2026 9:03 am ET1min read
AHG--
Akso Health Group has launched an exploratory patient support program in collaboration with Nanning Duoling Research Institute. The program aims to provide free in-hospital treatment plans for up to 10,000 eligible cancer patients through the integration of traditional Chinese medicine and modern medical technology. The partnership will connect radiation oncology centers with targeted drugs and remote consultation teams, addressing the urgent needs of cancer patients and reconstructing medical accessibility standards. The program will be subject to ongoing review and assessment of scalability and feasibility.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet